CNTB is trading at $2.56 (8.5% up) in pre-market, rebounding from yesterday’s 4.1% drop and extending its recent late-June rally.
- No fresh company-specific news, earnings, or regulatory announcements have been released since the prior session.
- The move is likely driven by speculative interest and volatility typical of thinly traded small-cap biotech stocks rather than a clear new catalyst.